Mohammad from Norway

Registered at the short selling broker StormGain, 2 minutes ago.

» Try StormGain you too
There is no percentage of traders loosing on crypto platforms.
Don't show again

CARA Therapeutics, Inc. (CARA) shares information

Cara Therapeutics Inc


24h Change

0.36 %

CARA

Live rate:

Stock data per Monday 8 Aug, 2022

CARA
NASDAQ
11.27
11.31
0.04 (+ 0.36%)
US Market is open

Live Stock price in graph for Cara Therapeutics Inc (CARA)

Data updated continously for CARA, showing up to the 500 most recent 100 data points

  • Latest Volume

    304,420 (-52.76 %)

  • Volume prev. day

    644,466

  • Avg. daily volume

    458,417

  • Market cap

    606,116,755

  • P/E ratio

    -6.28

  • Today high

    n/a

  • Today low

    n/a

  • 52 week high

    18.93 USD

  • 52 week low

    7.4 USD

  • YTD Change

    n/a

Quick links

 

Latest news about Cara Therapeutics Inc

Below you can find the most recent news posts about Cara Therapeutics Inc, primarily from US and UK based news sources.

Cara Therapeutics Q2 2022 Earnings Preview (NASDAQ:CARA)

Sunday, 7 August 2022, 23:35:00
Cara Therapeutics (CARA) is scheduled to announce Q2 earnings results on Monday, August 8th, after market close.The consensus EPS Estimate is -$0.24 (+60.7% Y/Y) and the consensus…
— Seeking Alpha


What Makes Cara Therapeutics Inc. (NASDAQ: CARA) One Of The Best Momentum Picks?

Saturday, 6 August 2022, 17:00:00
Cara Therapeutics Inc. (NASDAQ:CARA) shares, rose in value on Friday, 08/05/22, with the stock price up by 7.95% to the previous day’s close as strong demand from buyers drove the stock to $11.27. Actively observing the price movement in the last trading, the stock closed the session at $10.44, falling within a range of $10.18 … What Makes Cara Therapeutics Inc. (NASDAQ: CARA) One Of The Best Momentum Picks? Read More »
— Stocks Register


Cara Therapeutics, Inc. (CARA) to Present at the Canaccord Genuity 42nd Annual Growth Conference

Wednesday, 3 August 2022, 15:10:44
Cara Therapeutics to Present at the Canaccord Genuity 42nd Annual Growth Conference Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced that Christopher Posner, President and Chief Executive Officer, will present at the Canaccord Genuity 42nd Annual Growth Conference on Wednesday, August 10, 2022, at 9:30 a.m. ET. A webcast of the presentation can be accessed under “Events & Presentations” in the News & Investors section of the Company’s website at www.CaraTherapeutics.com. An archived webcast recording will be available on the Cara website for approximately 30 days. About Cara Therapeutics Cara Therapeutics is a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus. The Company’s novel KORSUVA™ (difelikefalin) injection is the first and only FDA-approved treatment for moderate-to-severe pruritus associated with chronic kidney disease in adults undergoing hemodialysis.
— Marijuana Stocks


Cara Therapeutics to Present at the Canaccord Genuity 42nd Annual Growth Conference

Wednesday, 3 August 2022, 13:00:00
STAMFORD, Conn., Aug. 03, 2022 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced that Christopher Posner, President and Chief Executive Officer, will present at the Canaccord Genuity 42 nd Annual Growth Conference on Wednesday, August 10, 2022, at 9:30 a.m. ET.
— GlobeNewswire


Top 5 2nd Quarter Trades of RHO CAPITAL PARTNERS INC

Tuesday, 2 August 2022, 01:00:08
Related Stocks: CHPT , ONTF , CARA , CHPT , NGM ,
— GuruFocus


Trading broker recommendation

We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €250 by bank
Description: Capital.com offer a large number of stocks for trading. Register an account today and check if they have CARA available or trade one of the many other CFD stocks they have.
Risk warning: 67.7% of retail investor accounts lose money when trading CFDs with Capital.